Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025 Manufacturer Bioxyne said it expects to resume revenue growth in the final quarter of the financial […]
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
Bioxyne upgrades revenue forecast on back of record Q2 by Martin Lane January 24, 2025January 29, 2025
Bioxyne sees sharp revenue growth as shares jump after strong quarter by Steve Jones October 17, 2024February 25, 2025
Company news: Rua Bioscience; Avecho; Bioxyne/BLS; iX Biopharma; Ecofibre; Zelira by Steve Jones and Martin Lane August 28, 2024January 13, 2025
BLS delivers first gummies manufactured under GMP licence by Martin Lane August 21, 2024January 13, 2025
Company news: Avecho; Bioxyne; Elixinol Wellness; IDT Australia; Melodiol Global Health; Zelira by Steve Jones July 31, 2024November 25, 2024
Ora Pharm launches plant processing and export services, inks deal with Breathe Life Sciences by Martin Lane July 2, 2024November 25, 2024
Company news: Ecofibre; Bioxyne/BLS; Aurora Cannabis by Steve Jones and Martin Lane May 14, 2024July 16, 2024
